Novobiocin does not inhibit DNA repair in an activve gene
- 1 January 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 7 (11) , 1917-1920
- https://doi.org/10.1093/carcin/7.11.1917
Abstract
Novobiocin, an inhibitor of type II topoisomerase, has been reported to inhibit u.v.-induced DNA repair in a number of established mammalian cell lines; we have confirmed this general observation in primary cultures of human epidermal keratinocytes. Using a recently developed technique for measuring pyrimidine dimer frequencies in genomic restriction fragments, we have determined the extent of DNA repair in the active, essential dihydrofolate reductase (DHFR) gene. Novobiocin did not affect repair of the DHFR gene in keratinocytes or in a Chinese hamster ovary (CHO) cell line over a 24-h period following irradiaton with 20 J/m2 u.v. These findings suggest that qualitative differences exist in the repair pathways in different genomic regions; topoisomerase II may not have an essential role in repair of active genes but may be required for repair of other regions in the genome.This publication has 2 references indexed in Scilit:
- COMPARATIVE EFFECTS OF GROWTH-INHIBITORS ON DNA-REPLICATION, DNA-REPAIR, AND PROTEIN-SYNTHESIS IN HUMAN EPIDERMAL-KERATINOCYTES1986
- Survival of UV-irradiated mammalian cells correlates with efficient DNA repair in an essential gene.Proceedings of the National Academy of Sciences, 1986